Cutler »

Acelyrin shares owned by Cutler

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Cutler from 13F filings

Historical chart of Cutler investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Cutler consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Cutler

Quarter filed Position value Share count Share price at filing
2024-03-31 $15k 2.3k 6.54
2023-12-31 $138k 19k 7.44
2023-09-30 $172k 17k 10.10

More positions owned by Cutler

Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Ishares Tr Us Home Cons Etf (ITB)
Madrigal Pharmaceuticals (MDGL)
Ishares Tr Ishares Semicdtr (SOXX)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Select Sector Spdr Tr Sbi Int-utils (XLU)
NVIDIA Corporation (NVDA)
Vanguard World Mega Grwth Ind (MGK)
Ishares Tr Rus 1000 Etf (IWB)
Spdr Gold Tr Gold Shs (GLD)
Select Sector Spdr Tr Technology (XLK)
Ishares Tr Russell 2000 Etf (IWM)
Coinbase Global Com Cl A (COIN)
Proshares Tr Ultrapro Qqq (TQQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Cutler

Top funds holding Acelyrin

Citadel Advisors
Vanguard Group
BlackRock
Opaleye Management
OrbiMed Advisors
venBio Partners
Artal Group
Jpmorgan Chase & Co
Samsara BioCapital
Ikarian Capital
Blue Owl Capital Holdings
Henderson Group
Decheng Capital
Logos Global Management
Kynam Capital Management

View all funds holding Acelyrin